Myriad Genetics Inc
NASDAQ:MYGN

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
NASDAQ:MYGN
Watchlist
Price: 22.22 USD -2.42% Market Closed
Market Cap: 2B USD
Have any thoughts about
Myriad Genetics Inc?
Write Note

Myriad Genetics Inc
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Myriad Genetics Inc
PP&E Gross Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Myriad Genetics Inc
NASDAQ:MYGN
PP&E Gross
$172.8m
CAGR 3-Years
10%
CAGR 5-Years
25%
CAGR 10-Years
17%
Abbvie Inc
NYSE:ABBV
PP&E Gross
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Myriad Genetics Inc's PP&E Gross?
PP&E Gross
172.8m USD

Based on the financial report for Jun 30, 2024, Myriad Genetics Inc's PP&E Gross amounts to 172.8m USD.

What is Myriad Genetics Inc's PP&E Gross growth rate?
PP&E Gross CAGR 10Y
17%

Over the last year, the PP&E Gross growth was -21%. The average annual PP&E Gross growth rates for Myriad Genetics Inc have been 10% over the past three years , 25% over the past five years , and 17% over the past ten years .

Back to Top